BRPI0911364A2 - tienopirimidinas - Google Patents
tienopirimidinasInfo
- Publication number
- BRPI0911364A2 BRPI0911364A2 BRPI0911364A BRPI0911364A BRPI0911364A2 BR PI0911364 A2 BRPI0911364 A2 BR PI0911364A2 BR PI0911364 A BRPI0911364 A BR PI0911364A BR PI0911364 A BRPI0911364 A BR PI0911364A BR PI0911364 A2 BRPI0911364 A2 BR PI0911364A2
- Authority
- BR
- Brazil
- Prior art keywords
- thienopyrimidines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102008017853A DE102008017853A1 (de) | 2008-04-09 | 2008-04-09 | Thienopyrimidine |
| PCT/EP2009/002112 WO2009124653A2 (de) | 2008-04-09 | 2009-03-23 | Thienopyrimidine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0911364A2 true BRPI0911364A2 (pt) | 2015-12-29 |
Family
ID=40765631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0911364A BRPI0911364A2 (pt) | 2008-04-09 | 2009-03-23 | tienopirimidinas |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20110028472A1 (pt) |
| EP (1) | EP2260044A2 (pt) |
| JP (1) | JP2011518132A (pt) |
| KR (1) | KR20110010721A (pt) |
| CN (1) | CN102015724A (pt) |
| AR (1) | AR071586A1 (pt) |
| AU (1) | AU2009235729A1 (pt) |
| BR (1) | BRPI0911364A2 (pt) |
| CA (1) | CA2720878A1 (pt) |
| DE (1) | DE102008017853A1 (pt) |
| EA (1) | EA201001576A1 (pt) |
| IL (1) | IL208066A0 (pt) |
| MX (1) | MX2010011015A (pt) |
| WO (1) | WO2009124653A2 (pt) |
| ZA (1) | ZA201007979B (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120101095A1 (en) * | 2009-06-22 | 2012-04-26 | Guenter Hoelzemann | Alkoxy-thienopyrimidines as tgf-beta receptor kinase modulators |
| KR101774035B1 (ko) | 2009-10-30 | 2017-09-01 | 얀센 파마슈티카 엔.브이. | 이미다조［１，２―ｂ］피리다진 유도체 및 ＰＤＥ１０ 저해제로서의 그의 용도 |
| BR112012018954A2 (pt) | 2010-02-05 | 2016-04-12 | Merck Patent Gmbh | derivados de hetaril-[1,8]naftiridina |
| SG183233A1 (en) | 2010-02-22 | 2012-09-27 | Merck Patent Gmbh | Hetarylaminonaphthyridines |
| AR080754A1 (es) | 2010-03-09 | 2012-05-09 | Janssen Pharmaceutica Nv | Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10 |
| WO2013000924A1 (en) | 2011-06-27 | 2013-01-03 | Janssen Pharmaceutica Nv | 1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES |
| FR2988722B1 (fr) | 2012-04-03 | 2014-05-09 | Sanofi Sa | Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques |
| WO2014001314A1 (en) | 2012-06-26 | 2014-01-03 | Janssen Pharmaceutica Nv | Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl- [1,2,4] triazolo [4,3-a] quinoxaline compounds and pde 10 inhibitors for use in the treatment of neurological or metabolic disorders |
| AU2013289284B2 (en) | 2012-07-09 | 2017-03-30 | Janssen Pharmaceutica Nv | Inhibitors of phosphodiesterase 10 enzyme |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5747469A (en) | 1991-03-06 | 1998-05-05 | Board Of Regents, The University Of Texas System | Methods and compositions comprising DNA damaging agents and p53 |
| GB9904387D0 (en) | 1999-02-25 | 1999-04-21 | Pharmacia & Upjohn Spa | Antitumour synergistic composition |
| EP1187633A4 (en) | 1999-04-08 | 2005-05-11 | Arch Dev Corp | USE OF ANTI-VEGF ANTIBODIES TO ENHANCE RADIATION IN ANTICANCER THERAPY |
| WO2005080377A1 (ja) * | 2004-02-20 | 2005-09-01 | Kirin Beer Kabushiki Kaisha | TGFβ阻害活性を有する化合物およびそれを含んでなる医薬組成物 |
| WO2006090094A1 (en) * | 2005-02-28 | 2006-08-31 | Vernalis R & D Ltd | Pyrimidothiophene compounds for use as hsp90 inhibitors |
| DE102005013621A1 (de) * | 2005-03-24 | 2006-09-28 | Curacyte Discovery Gmbh | Substituierte 2-Aryl(Hetaryl)-5-aminothieno[2,3-d]pyrimidin-6-carbonsäureamide, Verfahren zu ihrer Herstellung und Verwendung als Pharmazeutika |
| AU2007207536A1 (en) | 2006-01-17 | 2007-07-26 | Signal Pharmaceuticals, Llc | Inhibitors of TNFalpha, PDE4 and B-RAF, compositions thereof and methods of use therewith |
| WO2008020622A1 (en) * | 2006-08-17 | 2008-02-21 | Kyorin Pharmaceutical Co., Ltd. | NOVEL THIENO[2,3-d]PYRIMIDINE COMPOUND |
-
2008
- 2008-04-09 DE DE102008017853A patent/DE102008017853A1/de not_active Withdrawn
-
2009
- 2009-03-23 JP JP2011503357A patent/JP2011518132A/ja active Pending
- 2009-03-23 US US12/937,031 patent/US20110028472A1/en not_active Abandoned
- 2009-03-23 CA CA2720878A patent/CA2720878A1/en not_active Abandoned
- 2009-03-23 BR BRPI0911364A patent/BRPI0911364A2/pt not_active Application Discontinuation
- 2009-03-23 MX MX2010011015A patent/MX2010011015A/es not_active Application Discontinuation
- 2009-03-23 KR KR1020107025024A patent/KR20110010721A/ko not_active Withdrawn
- 2009-03-23 EA EA201001576A patent/EA201001576A1/ru unknown
- 2009-03-23 AU AU2009235729A patent/AU2009235729A1/en not_active Abandoned
- 2009-03-23 CN CN2009801122450A patent/CN102015724A/zh active Pending
- 2009-03-23 WO PCT/EP2009/002112 patent/WO2009124653A2/de not_active Ceased
- 2009-03-23 EP EP09731280A patent/EP2260044A2/de not_active Withdrawn
- 2009-04-08 AR ARP090101244A patent/AR071586A1/es unknown
-
2010
- 2010-09-07 IL IL208066A patent/IL208066A0/en unknown
- 2010-11-08 ZA ZA2010/07979A patent/ZA201007979B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN102015724A (zh) | 2011-04-13 |
| WO2009124653A3 (de) | 2009-12-03 |
| JP2011518132A (ja) | 2011-06-23 |
| DE102008017853A1 (de) | 2009-10-15 |
| IL208066A0 (en) | 2010-12-30 |
| AR071586A1 (es) | 2010-06-30 |
| ZA201007979B (en) | 2011-07-27 |
| US20110028472A1 (en) | 2011-02-03 |
| KR20110010721A (ko) | 2011-02-07 |
| EP2260044A2 (de) | 2010-12-15 |
| AU2009235729A1 (en) | 2009-10-15 |
| CA2720878A1 (en) | 2009-10-15 |
| EA201001576A1 (ru) | 2011-04-29 |
| MX2010011015A (es) | 2010-11-22 |
| WO2009124653A2 (de) | 2009-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3988147C0 (en) | INSERT SET | |
| DK2370462T3 (da) | Glucagon-analoger | |
| DK2342317T3 (da) | Hængende-dråbe-plade | |
| DE602009000234D1 (de) | msignals | |
| BRPI0907376A2 (pt) | Fotobiorretador | |
| DK3444343T3 (da) | Polypeptider | |
| BRPI0914649A2 (pt) | Piprazolo-quinazolinas | |
| DE602008003972D1 (de) | Sitzrücklehnungsmechanismus | |
| DE602008003521D1 (de) | Sitzrücklehnungsmechanismus | |
| DK2342454T3 (da) | Vindkraftanlæg | |
| DK2336132T3 (da) | Morpholinpurinderivat | |
| DK2335031T3 (da) | In-line-måler | |
| EP2308156A4 (en) | STEP ACTUATOR | |
| DK2379557T3 (da) | Aminopyrazol-forbindelse | |
| DK2271613T3 (da) | Hydroxymethylcyklohexylaminer | |
| DE602008003970D1 (de) | Strahlstromkalibriersystem | |
| EP2257170A4 (en) | TETRAHYDROFUROPYRIDONE | |
| EP2248964A4 (en) | DRILLING / TERMINAL DEVICE | |
| BRPI0907522A2 (pt) | biarlamidas | |
| DE112009000183A5 (de) | Sicherheitsvorreiber | |
| BRPI0909634A2 (pt) | 2-aminoquinolinas | |
| DE602009000862D1 (de) | Gehwagenbremse | |
| BRPI0911364A2 (pt) | tienopirimidinas | |
| DE112009001946A5 (de) | Mobelauszugsführung | |
| DE602009000488D1 (de) | Obstvereinzelvorrichtung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |